Fonte: Anti-Cancer Agents in Medicinal Chemistry. Unidades: FCFRP, FMRP
Assuntos: AMINOÁCIDOS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, LINHAGEM CELULAR, PROLIFERAÇÃO CELULAR, ÓXIDO NÍTRICO
ABNT
GASPARI, Ana Paula Segantin et al. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, v. 21, n. 12, p. 1602-1611, 2021Tradução . . Disponível em: https://doi.org/10.2174/0929867327666201020155105. Acesso em: 05 nov. 2024.APA
Gaspari, A. P. S., Silva, R. S. da, Carneiro, Z. A., Carvalho, M. R. de, Carvalho, I., Pernomian, L., et al. (2021). Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, 21( 12), 1602-1611. doi:10.2174/0929867327666201020155105NLM
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/0929867327666201020155105Vancouver
Gaspari APS, Silva RS da, Carneiro ZA, Carvalho MR de, Carvalho I, Pernomian L, Ferreira LP, Ramos LCB, Souza GA de, Formiga ALB. Improving cytotoxicity against breast cancer cells by using mixed-ligand ruthenium(II) complexes of 2,2 -bipyridine, amino acid, and nitric oxide derivatives as potential anticancer agents [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2021 ; 21( 12): 1602-1611.[citado 2024 nov. 05 ] Available from: https://doi.org/10.2174/0929867327666201020155105